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Background: Body composition of babies and how this may relate to later metabolic risk is an area of increasing interest, especially in preterm babies. There is a need for newborn body composition data specific to New Zealand's diverse and unique ethnic population that can be used as a reference.
Methods: Body composition by air displacement plethysmography (PEAPOD COSMED, USA) and anthropometry were measured within 5 days of birth in healthy, term infants born between 37 +0 and 41 +6 weeks' gestation in two hospitals in Auckland, New Zealand between 2015 and 2018. Ethnicity was parentidentified and prioritised according to Ministry of Health criteria. Data were analysed using ANOVA (GLM) post-hoc Tukey tests.
Results: 443 babies (54% male) were included. In females, mean (SD) fat-free mass (FFM, g) was higher in Pacific/M aori (PI/M, n = 81) and European (E, n = 39) than Middle Eastern/Latin/African/Asian (MLAAS, n = 85) (2910 (378) vs 2896 (363) and 2760 (361) g respectively; P = 0.03). PI/M males (n = 77) had significantly higher FFM compared to E (n = 65) and MLAAS males (n = 96) (3188 (386) vs 3004 (324) and 2884 (356) g; P < 0.0001) which was reflected in a significantly lower FM% (8.9 (4.0) vs 10.6 (4.0) and 10.5 (4.3) % respectively; P = 0.02). MLAAS male babies were significantly shorter than PI/M and E (50.7 (2.3) vs 51.6(2.1) and 51.9 (2.1) cm respectively; P < 0.0024).
Conclusions: There are both ethnic and gender differences in body composition. MLAAS male babies were the shortest and had the least fat-free mass but had greater FM% than PI/M. Background: Very premature infants have altered intestinal microbiota development compared with term infants. We evaluated longitudinally for the first year of life the microbiota acquisition in very preterm infants receiving different milk feeds with or without probiotics during early hospitalisation.
THE INFLUENCE OF FEEDING AND PROBIOTICS ON MICROBIOTA ACQUISITION OF VERY PREMATURE INFANTS DURING THE FIRST YEAR OF LIFE
Methods: Against a control group of 42 exclusively breastfed term infants, longitudinal stool samples collected (1 and 4 weeks, 4 and 12 months) from a total of 245 <32 weeks GA infants in 4 groups were studied (40 fed with mother's milk; 22 had standard formula supplement, 68 prebiotic formula supplement; and 88 treated with B breve M16V probiotics and had prebiotic formula supplement).
Results: The gut microbiota of premature infants differ to fullterm infants in delayed acquisition of strict anaerobes and increased predominance of facultative anaerobes. Shannon diversity index among preterm infants is lower in the human milk preterms compared with other groups. Difference in α diversity is highly significant at week 4. Preterms fed probiotics reversed many aspects of aberrant microbiota pattern. At 4 months, ratio of facultative to strict anaerobes and β diversity continued to differ between very preterm and term infants. At 1 year β diversities of all infants clustered closely within the nMDS graph.
Conclusions: Early microbiota development continue to differ in the first few months of life between term and very preterms. Probiotics promote a microbiota development closer to the full term breast fed infants. Studies are needed for a case of longer of probiotic/synbiotic treatment in very preterm infants.
IS UMBILICAL CORD BLOOD THERAPY AN EFFECTIVE TREATMENT FOR EARLY LUNG INJURY IN GROWTH-RESTRICTED NEWBORN LAMBS?
Allison BJ Background: Foetal growth restriction (FGR) and prematurity are often co-morbidities with both risk factors for lung disease. Despite advances in treatment, rates of ventilation-induced lung injury (VILI) remain high. Stem cell therapy can attenuate inflammation and injury associated with VILI in preterm animals. However, no studies have looked at the effects of stem cell therapy in FGR VILI. We aimed to determine if stem cell treatment could attenuate VILI in FGR lambs.
Methods: Preterm foetal sheep (0.6 gestation) underwent single umbilical artery ligation (SUAL) to induce FGR. Lambs were delivered preterm at~126dGA (term 150d), and randomised to either immediate euthanasia (unventilated controls; AG UVC & FGR UVC ) or 24hr ventilation (AG V & FGR V ) with a cohort receiving umbilical cord blood (UCB) treatment (AG CELLS , FGR CELLS ). Lungs were collected at post-mortem for histological and biochemical examination.
Results: Ventilation caused lung injury in AG lambs which was attenuated with UCB therapy. Ventilated FGR lambs also had lung injury, albeit with different indices compared to AG lambs. Following ventilation septal crests, alpha smooth muscle actin and cell proliferation were all decreased (P<0.05) in FGR lungs. UCB treatment in ventilated FGR lambs further decreased septal crest density and increased collagen deposition, however also increased angiogenesis.
Conclusions: Our data demonstrate that the uterine environment can impact on treatment efficacy. Our findings show potential
